Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods

详细信息    查看全文

• 作者：Mona Jaberidoost (1)
  Laya Olfat (2)
  Alireza Hosseini (3)
  Abbas Kebriaeezadeh (1) (4)
  Mohammad Abdollahi (1) (4)
  Mahdi Alaeddini (5)
  Rassoul Dinarvand (1) (6)
  
  1. Department of Pharmacoeconomics and Pharmaceutical Administration ; Faculty of Pharmacy ; Tehran University of Medical Sciences ; Tehran ; 1417614411 ; Iran
  2. Management Department ; Allame Tabatabaei University ; Tehran ; Iran
  3. Food and Drug Organization ; Ministry of Health and Medical Education ; Tehran ; Iran
  4. Department of Toxicology and Pharmacology ; Faculty of Pharmacy and Pharmaceutical Sciences Research Center ; Tehran University of Medical Sciences ; Tehran ; Iran
  5. Department of Industrial Engineering ; University of Science and Culture ; Tehran ; Iran
  6. Department of Pharmaceutics ; Faculty of Pharmacy ; Tehran University of Medical Sciences ; Tehran ; Iran
  
• 关键词：Pharmaceutical supply chain ; Risk assessment ; analytic hierarchy process (AHP) method ; Simple additive weighting (SAW) method ; Iran pharmaceutical industry
• 刊名：Journal of Pharmaceutical Policy and Practice
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：8
• 期：1
• 全文大小：1,002 KB
• 参考文献：1. Hogerzeil, HV (2006) Essential medicines and human rights: what can they learn from each other?. B World Health Organ 84: pp. 371-375 CrossRef
  2. Jaberidoost, M, Nikfar, S, Abdollahiasl, A, Dinarvand, R (2013) Pharmaceutical supply chain risks: a systematic review. Daru 21: pp. 69 CrossRef
  3. Kaufmann L, Thiel C and Becker A. Supply chain management in the Mexican pharmaceutical industry. Paper presented at 16th annual North American research/teaching symposium on purchasing and supply chain management. Conference Year Conference.
  4. Shah, N (2005) Process industry supply chains: advances and challenges. Comput Chem Eng 29: pp. 1225-1235 CrossRef
  5. Henry, D, Lexchin, J (2002) The pharmaceutical industry as a medicines provider. Lancet 360: pp. 1590-1595 CrossRef
  6. Mehralian, G, Gatari, AR, Morakabati, M (2012) Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies. Iran J Pharm Res 11: pp. 209-219
  7. Craighead, CW, Blackhurst, J, Rungtusanatham, MJ (2007) The severity of supply chain disruptions: design characteristics and mitigation capabilities. Decision Sci 38: pp. 131-156 CrossRef
  8. Dinarvand R. New national drug policy in Iran leading to expanded pharmaceutical market and extended access of public to medicines. Iranian J Public Health / . 2009; 38(Suppl. 1).
  9. Enyinda, CI, Mbah, CH, Ogbuehi, A (2010) An empirical analysis of risk mitigation in the pharmaceutical industry supply chain: a developing country perspective. Thunderbird International Business Review 52: pp. 45-54 CrossRef
  10. Shah, N (2004) Pharmaceutical supply chains: key issues and strategies for optimisation. Comput Chem Eng 28: pp. 929-941 CrossRef
  11. Farshchi A, Jaberidoost M, Abdollahiasl A et al. Efficacies of regulatory policies to control massive use of diphenoxylate. Int J Pharmacol. 2012; 8(5).
  12. Dinarvand R. A new pharmaceutical environment in iran: Marketing impacts. Iran J Pharm Res / . 2010: 1鈥?.
  13. Naraharisetti, P, Karimi, I (2010) Supply chain redesign and new process introduction in multipurpose plants. Chem Eng Sci 65: pp. 2596-2607 CrossRef
  14. Jaberidoost, M, Abdollahiasl, A, Farshchi, A (2012) Risk management in Iranian pharmaceutical companies to ensure accessibility and quality of medicines. Value Health 15: pp. A616-A617 CrossRef
  15. J眉ttner, U, Christopher, M, Baker, S (2007) Demand chain management-integrating marketing and supply chain management. Ind Market Manag 36: pp. 377-392 CrossRef
  16. Breen, L (2008) A preliminary examination of risk in the pharmaceutical supply chain (psc) in the national health service (nhs), uk. J Serv Sci Manag 1: pp. 6
  17. Vanany, I, Zailani, S, Pujawan, N (2009) Supply chain risk management: literature review and future research. Int J Inform Syst Suppl Chain Manag 2: pp. 16-33 CrossRef
  18. Al-Bahar, JF, Crandall, KC (1990) Systematic risk management approach for construction projects. J Constr Eng Manag 116: pp. 533-546 CrossRef
  19. Kleindorfer, PR, Saad, GH (2005) Managing disruption risks in supply chains. Prod Oper Manag 14: pp. 53-68 CrossRef
  20. J眉ttner, U (2005) Supply chain risk management: understanding the business requirements from a practitioner perspective. Int J Logistics Manag 16: pp. 120-141 CrossRef
  21. FDA U. Guidance for industry. Q9 Quality Risk Management. Rockville, MD. 2006.
  22. Norrman A and Lindroth R. Categorization of supply chain risk and risk management. Suppl Chain Risk. 2004: 14鈥?7.
  23. Zsidisin, GA, Ellram, LM, Carter, JR (2004) An analysis of supply risk assessment techniques. Int J Phys Distr Log 34: pp. 397-413 CrossRef
  24. Enyinda, CI, Mbah, CHN, Ogbuehi, A (2010) An empirical analysis of risk mitigation in the pharmaceutical industry supply chain: a developing-country perspective. Thunderbird International Business Review 52: pp. 45-54 CrossRef
  25. Andrich, D (1978) Application of a psychometric rating model to ordered categories which are scored with successive integers. Appl Psychol Meas 2: pp. 581-594 CrossRef
  26. Saaty TL. The analytic hierarchy process. Springer; 1989:59鈥?7.
  27. Saaty TL. Analytic hierarchy process. Encyclopedia of Operations Research and Management Science. 2001: 19鈥?8
  28. Saaty, TL (1990) How to make a decision: the analytic hierarchy process. Eur J Oper Res 48: pp. 9-26 CrossRef
  29. Altuzarra, A, Moreno-Jim茅nez, JM, Salvador, M (2010) Consensus building in ahp-group decision making: a Bayesian approach. Oper Res 58: pp. 1755-1773 CrossRef
  30. Chen, C-F (2006) Applying the analytical hierarchy process (ahp) approach to convention site selection. J Travel Res 45: pp. 167-174 CrossRef
  31. Escobar, MT, Moreno-jim茅nez, JM (2007) Aggregation of individual preference structures in ahp-group decision making. Group Decis Negot 16: pp. 287-301 CrossRef
  32. Memariania, A, Aminib, A, Alinezhadc, A (2009) Sensitivity analysis of simple additive weighting method (saw): The results of change in the weight of one attribute on the final ranking of alternatives. J Ind Eng 4: pp. 13-18
  33. Yoon KP and Hwang C-L. Multiple attribute decision making: An introduction. Sage; 1995.
  
• 刊物主题：Medicine/Public Health, general; Pharmacy;
• 出版者：BioMed Central
• ISSN：2052-3211

文摘

Objectives Pharmaceutical supply chain is a significant component of the health system in supplying medicines, particularly in countries where main drugs are provided by local pharmaceutical companies. No previous studies exist assessing risks and disruptions in pharmaceutical companies while assessing the pharmaceutical supply chain. Any risks affecting the pharmaceutical companies could disrupt supply medicines and health system efficiency. The goal of this study was the risk assessment in pharmaceutical industry in Iran considering process's priority, hazard and probability of risks. Methods The study was carried out in 4 phases; risk identification through literature review, risk identification in Iranian pharmaceutical companies through interview with experts, risk analysis through a questionnaire and consultation with experts using group analytic hierarchy process (AHP) method and rating scale (RS) and risk evaluation of simple additive weighting (SAW) method. Results In total, 86 main risks were identified in the pharmaceutical supply chain with perspective of pharmaceutical companies classified in 11 classes. The majority of risks described in this study were related to the financial and economic category. Also financial management was found to be the most important factor for consideration. Conclusion Although pharmaceutical industry and supply chain were affected by current political conditions in Iran during the study time, but half of total risks in the pharmaceutical supply chain were found to be internal risks which could be fixed by companies, internally. Likewise, political status and related risks forced companies to focus more on financial and supply management resulting in less attention to quality management.